Profil
Mark J.
Daniel is Chief Financial & Accounting Officer at Atossa Therapeutics, Inc. since 2025.
Formerly, Mr. Daniel was Senior Vice President-Finance at Bruker Spatial Biology, Inc. from 2017 to 2025 and Corporate Secretary at HS Winddown, Inc. from 2011 to 2013.
Mr. Daniel completed undergraduate education at Washington State University.
Postes actifs de Mark Daniel
| Sociétés | Poste | Début |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Directeur Financier/CFO | 14/10/2025 |
Anciens postes connus de Mark Daniel
| Sociétés | Poste | Fin |
|---|---|---|
HS Winddown, Inc.
HS Winddown, Inc. Medical SpecialtiesHealth Technology Manufactures water purifier appliances | Comptroller/Controller/Auditor | - |
Formation de Mark Daniel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
HS Winddown, Inc.
HS Winddown, Inc. Medical SpecialtiesHealth Technology Manufactures water purifier appliances | Health Technology |
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Washington State University
Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















